3D-printed simulator for nasopharyngeal swab collection for COVID-19.


Journal

Infectious diseases now
ISSN: 2666-9919
Titre abrégé: Infect Dis Now
Pays: France
ID NLM: 101775152

Informations de publication

Date de publication:
May 2022
Historique:
received: 01 12 2021
revised: 05 01 2022
accepted: 02 02 2022
pubmed: 13 2 2022
medline: 10 6 2022
entrez: 12 2 2022
Statut: ppublish

Résumé

Diagnosis of COVID-19 is essential to prevent the spread of SARS-CoV-2. Nasopharyngeal swabs (NPS) remain the gold standard in screening, although associated with false negative results (up to 30%). We developed a 3D simulator of the nasal and pharyngeal cavities for the learning and improvement of NPS collection. Simulator training sessions were carried out in 11 centers in France. A questionnaire assessing the simulator was administered at the end of the sessions. The study population included both healthcare workers (HCW) and volunteers from the general population. Out of 589 participants, overall satisfaction was scored 9.0 [8.9-9.1] on a scale of 0 to 10 with excellent results in the 16 evaluation items of each category (HCWs and general population, NPS novices and experienced). The simulator was considered very realistic (95%), easy to use (97%), useful to understand the anatomy (89%) and NPS sampling technique (93%). This educational tool was considered essential (93%). Participants felt their future NPS would be more reliable (72%), less painful (70%), easier to perform (88%) and that they would be carried out more serenely (90%). The mean number of NPS conducted on the simulator to feel at ease was two; technical fluency with the simulator can thus be acquired quickly. Our simulator, whose 3D printing can be reproduced freely using a permanent open access link, is an essential educational tool to standardize the learning and improvement of NPS collection. It should enhance virus detection and thus contribute to better pandemic control.

Identifiants

pubmed: 35149235
pii: S2666-9919(22)00035-5
doi: 10.1016/j.idnow.2022.02.002
pmc: PMC8824092
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

138-144

Informations de copyright

Copyright © 2022 Elsevier Masson SAS. All rights reserved.

Références

N Engl J Med. 2020 May 21;382(21):1969-1973
pubmed: 32227757
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
Eur Arch Otorhinolaryngol. 2020 Oct;277(10):2947-2948
pubmed: 32519081
Nature. 2021 Apr;592(7854):438-443
pubmed: 33690265
N Engl J Med. 2020 Jul 30;383(5):494-496
pubmed: 32492294
Eur Respir J. 2021 Apr 8;57(4):
pubmed: 33303542
J Med Virol. 2021 Feb;93(2):719-725
pubmed: 32706393
Lancet. 2021 Feb 20;397(10275):682-694
pubmed: 33524311
N Engl J Med. 2020 Mar 19;382(12):1177-1179
pubmed: 32074444
N Engl J Med. 2020 Apr 23;382(17):e37
pubmed: 32237671
N Engl J Med. 2021 Jan 21;384(3):197-199
pubmed: 33472283
Otolaryngol Head Neck Surg. 2020 Aug;163(2):271-274
pubmed: 32482155
Eur Arch Otorhinolaryngol. 2021 Jul;278(7):2649-2651
pubmed: 33156390
JAMA Otolaryngol Head Neck Surg. 2020 Nov 1;146(11):993-994
pubmed: 32940647
Lancet. 2021 Feb 6;397(10273):469-470
pubmed: 33485462
Clin Infect Dis. 2021 Nov 2;73(9):e3106-e3109
pubmed: 33075138
Lancet. 2020 Oct 31;396(10260):e71-e72
pubmed: 33069277
N Engl J Med. 2020 May 28;382(22):e76
pubmed: 32302471
Oral Oncol. 2021 Feb;113:105033
pubmed: 33041213
JAMA Otolaryngol Head Neck Surg. 2020 Dec 1;146(12):1179-1181
pubmed: 33022069
N Engl J Med. 2020 Aug 6;383(6):e38
pubmed: 32502334
N Engl J Med. 2020 Dec 17;383(25):2427-2438
pubmed: 32991794
Eur J Neurol. 2021 Nov;28(11):e91-e92
pubmed: 33480112
Diagnostics (Basel). 2020 Sep 09;10(9):
pubmed: 32916801
Nature. 2021 Jan;589(7841):177-178
pubmed: 33432212
Eur Arch Otorhinolaryngol. 2020 Jul;277(7):2155-2157
pubmed: 32383097
PLoS One. 2021 Jun 10;16(6):e0253007
pubmed: 34111196
Nat Med. 2020 May;26(5):681-687
pubmed: 32327758
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Emerg Microbes Infect. 2020 Dec;9(1):747-756
pubmed: 32196430
N Engl J Med. 2021 Jan 7;384(1):80-82
pubmed: 33270381
Int J Infect Dis. 2020 May;94:107-109
pubmed: 32315809

Auteurs

A Koch (A)

Obstetrics department, Strasbourg university hospital, Strasbourg, France. Electronic address: antoine.koch@chru-strasbourg.fr.

M Vermel (M)

Obstetrics department, Strasbourg university hospital, Strasbourg, France.

Y Hansmann (Y)

Infectious diseases department, Strasbourg university hospital, Strasbourg, France.

M Lodi (M)

Obstetrics department, Strasbourg university hospital, Strasbourg, France; CNRS UMR 7104, Inserm U964, Institute of genetics and molecular and cellular biology (IGBMC), Illkirch-Graffenstaden, France.

C Mura (C)

Infectious diseases department, Strasbourg university hospital, Strasbourg, France.

A Sananes (A)

Obstetrics department, Strasbourg university hospital, Strasbourg, France.

S Gallien (S)

Infectious diseases department, Créteil hospital, Créteil, France.

É Wurtz (É)

Infectious diseases department, Saverne hospital, Saverne, France.

A Bleibtreu (A)

Infectious diseases department, Pitié-Salpêtrière hospital, Paris, France.

M Martinot (M)

Infectious diseases department, Pasteur hospital, Colmar, France.

J Exinger (J)

Medical biology laboratory, Haguenau hospital, Haguenau, France.

X Lescure (X)

Infectious diseases department, Bichat hospital, Paris, France.

S Kerneis (S)

Infectious diseases department, Cochin hospital, Paris, France.

K Lacombe (K)

Infectious diseases department, Saint-Antoine hospital, Paris, France.

J Y Mootien (JY)

Medical Intensive Care Unit, Mulhouse and South Alsace Regional hospital Center, Mulhouse, France.

C Shawali (C)

Medical biology laboratory, Sélestat Hospital, Sélestat, France.

L Lecointre (L)

Obstetrics department, Strasbourg university hospital, Strasbourg, France; I-Cube UMR 7357, Engineering, Information Processing and Image Sciences Lab, Strasbourg university, Strasbourg, France.

C Debry (C)

Inserm UMR-S 1121 'Biomaterials and Bioengineering', Strasbourg university, Strasbourg, France; ENT Department, Strasbourg University Hospital, Strasbourg, France.

N Lefebvre (N)

Infectious diseases department, Strasbourg university hospital, Strasbourg, France.

N Sananes (N)

Obstetrics department, Strasbourg university hospital, Strasbourg, France; Inserm UMR-S 1121 'Biomaterials and Bioengineering', Strasbourg university, Strasbourg, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH